AVIR · Atea Pharmaceuticals, Inc.
$4.81
-0.06 (-1.23%)
At close · Jul 22
Market Cap
$384.93M
Shares
80.03M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-22 | 2026-06-18 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-27 | 2026-06-18 | |
| 8-K | 2026-03-05 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| Investor Event Transcript | 2025-09-30 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-20 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-29 | 2025-06-20 | |
| 8-K | 2025-04-17 | 2025-04-16 | |
| 8-K | 2025-04-01 | 2025-03-31 | |
| 8-K | 2025-03-24 | 2025-03-21 | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2025-02-24 | 2025-02-20 | |
| 8-K | 2025-01-14 | 2025-01-13 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-06-21 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | — | |
| DEF 14A | 2024-04-26 | 2024-06-21 | |
| 8-K | 2024-02-28 | — | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-06-21 | 2023-06-16 | |
| 10-Q | 2023-05-08 | 2023-03-31 | |
| 8-K | 2023-05-08 | — | |
| DEF 14A | 2023-04-28 | 0001-01-01 | |
| 10-K | 2023-02-28 | 2022-12-31 | |
| 8-K | 2023-02-28 | — | |
| 8-K | 2022-11-07 | — | |
| 10-Q | 2022-11-07 | 2022-09-30 | |
| 8-K | 2022-08-08 | — | |
| 10-Q | 2022-08-08 | 2022-06-30 | |
| 8-K | 2022-06-21 | 2022-06-17 | |
| 10-Q | 2022-05-10 | 2022-03-31 | |
| 8-K | 2022-05-10 | — |
Showing 1–50 of 70 filings
Key facts
CIK
1593899
CUSIP
04683R106
13F (30d)
13 filings
13 filers
Visit website
Investor relations